Month: March 2020 - SpringTide Investments

SpringTide was a Major Investor in PathologyWatch’s $3M Series Seed round in early 2019, taking a board seat. We continued to support the company through 2019 with Elastic Sales, building the in-house sales force, and led PathologyWatch’s $5M Series A round in early 2020, doubling the valuation within one year.

Archive for March 2020

PathologyWatch Radically Improves Skin Cancer Diagnostics for Dermatologists

SpringTide is the only venture health fund that helps healthcare AI companies solving big problems sell into the market for entrepreneurs and venture partners alike.